Effects of long-term antihypertensive treatment with lisinopril on resistance arteries in hypertensive patients with left ventricular hypertrophy

Journal of Hypertension

Volumn 15, Issue 2, 1997, Pages 197-204

  Rizzoni, Damiano ^a   Muiesan, Maria Lorenza ^a   Porteri, Enzo ^a   Castellano, Maurizio ^a   Zulli, Roberto ^a   Bettoni, Giorgio ^a   Salvetti, Massimo ^a   Monteduro, Cristina ^a   Agabiti Rosei, Enrico ^a,b  

^a UNIVERSITY OF BRESCIA   (Italy)

^b SPEDALI CIVILI   (Italy)

Author keywords

Acetylcholine; Angiotensin converting enzyme inhibitors; Endothelium; Endothelium derived relaxing factor; Hypertrophy; Lisinopril; Vascular hypertrophy; Vascular resistance

Indexed keywords

ACETYLCHOLINE; LISINOPRIL;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTERY MEDIA; ARTICLE; BLOOD PRESSURE MEASUREMENT; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTROCARDIOGRAM; ESSENTIAL HYPERTENSION; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; RESISTANCE BLOOD VESSEL; RETROSPECTIVE STUDY; SUBCUTANEOUS FAT; VASCULAR ENDOTHELIUM; VASODILATATION;

EID: 0031044775     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-199715020-00011     Document Type: Article

References (33)

1. Aalkjær C, Haegerty AM, Petersen KK, Swales JD, Mulvany MJ: Evidence for increased media thickness, increased neural amine uptake, and depressed excitation-contraction coupling in isolated resistance vessels from essential hypertensives. Circ Res 1987, 61:181-186.
2. Baumbach GL, Heistad DD: Remodeling of cerebral arterioles in chronic hypertension. Hypertension 1989, 13:968-972.
3. Heagerty AM, Aalkjær C, Bund SJ, Korsgaard N, Mulvany MJ: Small artery structure in hypertension. Dual process of remodeling and growth. Hypertension 1993, 21:391-397.
4. Schiffrin EL, Deng LY, Larochelle P: Effects of a β-blocker or a converting enzyme inhibitor on resistance arteries in essential hypertension. Hypertension 1994, 23:83-91.
5. Thybo NK, Stephens N, Cooper A, Aalkjær C, Heagerty AM, Mulvany MJ: Effect of antihypertensive treatment on small arteries of patients with previously untreated essential hypertension. Hypertension 1995, 25:474-481.
6. Sihm I, Schroeder AP, Aalkjær C, Holm M, Morn B, Mulvany MJ, et al.: Normalization of resistance artery structure and left ventricular morphology with a perindopril-based regimen. Can J Cardiol 1994; 10 (suppl D):30D-32D.
7. Schiffrin EL, Deng LY: Comparison of effects of angiotensin I-converting enzyme inhibition and β-blockade for 2 years on function of small arteries from hypertensive patients. Hypertension 1995, 25:699-703.
8. Thürmann PA, Stephens N, Heagerty AM, Kenedi P, Weidinger G, Rietbrock N: Influence of isradipine and spirapril on left ventricular hypertrophy and resistance arteries. Hypertension 1996, 28:450-456.
9. The SAMPLE Study Group: Ambulatory blood pressure is superior to clinic blood pressure in predicting treatment-induced regression of left ventricular hypertrophy. Circulation 1996, (in press).
10. Devereux RB, Reichek N: Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 1977, 55:613-618.
11. Agabiti-Rosei E, Muiesan ML, Rizzoni D, Zulli R, Calebich S, Castellano M, et al.: Cardiovascular structural changes and calcium antagonist therapy in patients with hypertension. J Cardiovasc Pharmacol 1994, 24 (suppl A):S37-S43.
12. Rizzoni D, Muiesan ML, Montani G, Zulli R, Calebich S, Agabiti Rosei E: Relationship between initial cardiovascular structural changes and daytime and nighttime blood pressure monitoring. Am J Hypertens 1992, 5:180-186.
13. Savage DD, Garrison RJ, Kannel WB, Levy, D, Anderson SJ, Stokes, J, et al.: The spectrum of left ventricular hypertrophy in a general population sample: the Framingham study. Circulation 1987, 75 (suppl 1):126-130.
14. Devereux RB, Lutas EM, Casale PN, Kligfield P, Eisenberg RR, Hammond IW, et al.: Standardization of M-mode echocardiographic left ventricular anatomic measurements. J Am Coll Cardiol 1984, 4:1222-1230.
15. Aalkjær C, Eiskjær H, Mulvany MJ, Jespersen B, Kjær T, Sorensen SS, et al.: Abnormal structure and function of isolated subcutaneous resistance vessels from essential hypertensive patients despite antihypertensive treatment. J Hypertens 1989, 7:305-310.
16. Agabiti-Rosei E, Rizzoni D, Castellano M, Porteri E, Zulli R, Muiesan ML, et al.: Media:lumen ratio in human small resistance arteries is related to forearm minimal vascular resistance. J Hypertens 1995, 13:341-347.
17. Mulvany MJ, Hansen PK, Aalkjær C: Direct evidence that the greater contractility of resistance vessels in spontaneously hypertensive rats is associated with a narrowed lumen, a thickened media, and an increased number of smooth muscle cell layers. Circ Res 1978, 43:854-864.
18. Rizzoni D, Castellano M, Porteri E, Bettoni G, Muiesan ML, Agabiti Rosei E. Delayed development of hypertension after short-term nitrendipine treatment. Hypertension 1994, 24:131-139.
19. Rizzoni D, Castellano M, Porteri E, Bettoni G, Muiesan ML, Cinelli A, et al.: Effects of low and high doses of fosinopril on the structure and function of resistance arteries. Hypertension 1995, 26:118-123.
20. Schiffrin EL, Deng LY, Larochelle P: Progressive improvement in the structure of resistance arteries of hypertensive patients after 2 years of treatment with an angiotensin I-converting enzyme inhibitor. Comparison with effects of a β-blocker. Am J Hypertens 1995, 8:229-236.
21. Shaw LM, George PR, Oldham AA, Heagerty AM: A comparison of the effect of angiotensin converting enzyme inhibition and angiotensin II receptor antagonism on the structural changes associated with hypertension in rat small arteries. J Hypertens 1995, 13:1135-1143.
22. Chen DG, Jin XQ, Wang HJ, Chen SC: Mechanisms responsible for sustained hypotension after captopril treatment. J Hypertens 1995, 13:1113-1121.
23. Thybo NK, Korsgaard N, Eriksen S, Christensen KL, Mulvany MJ: Dose-dependent effects of perindopril on blood pressure and small artery structure. Hypertension 1994, 23:659-666.
24. Harrap SB, Van der Merwe WM, Griffin SA, MacPherson F, Lever AF: Brief angiotensin converting enzyme inhibitor treatment in young spontaneously hypertensive rats reduces blood pressure long term. Hypertension 1990, 16:603-614.
25. Adams MA, Bobik A, Korner PI: Enalapril can prevent vascular amplifier development in spontaneously hypertensive rats. Hypertension 1990, 16:252-260.
26. Rizzoni D, Castellano M, Porteri E, Bettoni G, Muiesan ML, Agabiti-Rosei E: Vascular structural and functional alterations before and after the development of hypertension in SHR. Am J Hypertens 1994, 7:193-200.
27. Rizzoni D, Porteri E, Castellano M, Bettoni G, Muiesan ML, Muiesan P, et al.: Vascular hypertrophy and remodeling in secondary hypertension. Hypertension 1996, 28:785-790.
28. Dohi Y, Criscione L, Pfeiffer K, Lüscher TF: Angiotensin blockade or calcium antagonists improve endothelial dysfunction in hypertension: studies in perfused mesenteric resistance arteries. J Cardiovasc Pharmacol 1994, 24:372-379.
29. Panza JA, Quyyumi AA, Callahan TS, Epstein SE: Effects of antihypertensive treatment on endothelium-dependent vascular relaxation in patients with essential hypertension. Am J Coll Cardiol 1993, 21:1145-1151.
30. Creager MA, Roddy MA: Effect of captopril and enalapril on endothelial function in hypertensive patients. Hypertension 1994, 24:499-505.
31. Kiowski W, Linder L, Nuesch R, Martina B: Effects of cilazapril on vascular structure and function in essential hypertension. Hypertension 1996, 27:371-376.
32. Hirooka Y, Imaizumi T, Masaki H, Aando S, Harada S, Momohera M, et al.: Captopril improves impaired endothelium-dependent vasodilatation in hypertensive patients. Hypertension 1992, 20:175-180.
33. Mattei P, Taddei S, Ghiadoni L, Virdis A, Parrucci M, Salvetti A: Effects of lisinopril of endothelial function in hypertensive patients [abstract]. J Hypertens 1996, 14 (suppl 1):S48.